
MCOA
Healthcare · Drug Manufacturers - Specialty & Generic · $220,765 market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2019
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 21, 2022 | After the close | — | -0.00 | — |
| Aug 22, 2022 | Time not confirmed | — | -0.00 | — |
| Apr 15, 2022 | Time not confirmed | — | -0.00 | — |
| Nov 17, 2021 | Time not confirmed | — | -0.00 | — |
| Aug 20, 2021 | Time not confirmed | — | -0.00 | — |
| Apr 14, 2021 | Time not confirmed | — | -0.00 | — |
| Mar 31, 2021 | Time not confirmed | — | -0.00 | — |
| Nov 16, 2020 | Time not confirmed | — | -0.00 | — |
| Aug 14, 2020 | Time not confirmed | — | -0.00 | — |
| May 14, 2020 | Time not confirmed | — | -0.13 | — |
| Mar 31, 2020 | Time not confirmed | — | -0.02 | — |
| Nov 19, 2019 | Time not confirmed | — | -0.13 | — |
| Aug 19, 2019 | Time not confirmed | — | -0.13 | — |
Marijuana Company of America, Inc., together with its subsidiaries, develops, produces, and distributes cannabis and cannabidiol (CBD) products under the hempSMART brand name in the United States. The company offers hempSMART products comprising hempSMART Brain, a patented and formulated personal care consumer product for brain wellness; hempSMART Pain capsules for temporary relief of minor discomfort with physical…
| Time not confirmed |
| — |
| -0.01 |
| — |
| Mar 31, 2019 | Time not confirmed | — | -0.11 | — |
| Nov 19, 2018 | Time not confirmed | — | 0.06 | — |
| Aug 17, 2018 | Time not confirmed | — | 0.06 | — |
| May 21, 2018 | Time not confirmed | — | -0.21 | — |
| Mar 31, 2018 | Time not confirmed | — | 0.12 | — |